Morpho, unveiled at CPHI 2024, is the new brand identity of Alfasigma's CDMO, a trusted partner in contract pharmaceutical development and manufacturing offering tailored, high-quality third-party production. With more than 60 years of experience and a strong network across Europe and the USA, Morpho takes a customer-centric approach with the same high standards as Alfasigma's own branded products, supported by an integrated development-to-manufacturing model that ensures flexibility, efficiency and innovation.

Aucun commentaire disponible.
Laissez votre note & commentaire